Underwritten common stock offering
Company: TeraWulf
The claim, verbatim
Entered into Underwriting Agreement for offering of 36,764,706 shares of common stock with estimated gross proceeds of approximately $25 million, closing expected on or about February 6, 2023
Source (primary)
TeraWulf 8-K filed 2023-02-02 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “On February 1, 2023, TeraWulf Inc. (the "Company") entered into an Underwriting Agreement (the "Underwriting Agreement") with JonesTrading Institutional Services LLC, as representative of the several underwriters (the "Underwriters"), relating to an underwritten offering of 36,764,706 shares (the "Company Shares") of its $0.001 par value common stock (the "Offering"). The Company estimates that gross proceeds from the Offering will be approximately $25 million, before deducting underwriting discounts and commissions and estimated Offering expenses, and assuming no exercise of the Underwriters' over-allotment option. The closing of the offering is expected to take place on or about February 6, 2023, subject to the satisfaction of customary closing conditions.”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms TeraWulf 8-K filed 2023-02-02
Quote: “On February 1, 2023, TeraWulf Inc. (the "Company") entered into an Underwriting Agreement (the "Underwriting Agreement") with JonesTrading Institutional Services LLC, as representative of the several underwriters (the "Underwriters"), relating to an underwritten offering of 36,764,706 shares (the "Company Shares") of its $0.001 par value common stock (the "Offering"). The Company estimates that gross proceeds from the Offering will be approximately $25 million, before deducting underwriting discounts and commissions and estimated Offering expenses, and assuming no exercise of the Underwriters' over-allotment option. The closing of the offering is expected to take place on or about February 6, 2023, subject to the satisfaction of customary closing conditions.”